Related Experiment Video
Updated: Aug 15, 2026
05:39
Quantitative Measurement of GLUT4 Translocation to the Plasma Membrane by Flow Cytometry
Published on: November 8, 2010
Summary
Purchasers of health care services will significantly impact the quality, efficiency, and accessibility of care. Providers must ensure purchasers have adequate information for informed decision-making to achieve positive healthcare system changes.
Area of Science:
- Health Policy
- Healthcare Management
- Health Economics
Background:
- The U.S. healthcare system is at a critical juncture, with significant changes anticipated.
- Purchasers of healthcare services are positioned to be the primary decision-makers influencing the system's future direction.
Purpose of the Study:
- To explore the pivotal role of purchasers in shaping the healthcare system's quality, efficiency, and accessibility.
- To delineate the responsibilities of various stakeholders in navigating upcoming healthcare reforms.
- To analyze the potential positive and negative outcomes based on purchasers' decisions.
Main Methods:
- Qualitative analysis of the healthcare landscape and stakeholder roles.
- Exploration of decision-making processes for healthcare purchasers.
- Examination of the influence of provider information dissemination on purchaser choices.
Main Results:
- Purchaser decisions hold the potential to substantially improve or degrade healthcare quality, efficiency, and accessibility for all Americans.
- Failure by purchasers to make informed decisions could lead to a sharp decline in medical care and coverage standards.
Conclusions:
- Healthcare providers have a vested interest and ethical obligation to equip purchasers with the necessary information for sound decision-making.
- Strategic actions by purchasers are crucial for realizing the promise of a better healthcare system and avoiding detrimental outcomes.
Related Concept Videos
01:32Secondary Active Transport
One example of how cells use the energy contained in electrochemical gradients is demonstrated by glucose transport into cells. The ion vital to this process is sodium (Na+), which is typically present in higher concentrations extracellularly than in the cytosol. Such a concentration difference is due, in part, to the action of an enzyme "pump" embedded in the cellular membrane that actively expels Na+ from a cell. Importantly, as this pump contributes to the high concentration of...
01:27Glucose Transporters
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
01:26Glucose Absorption Into the Small Intestine
Complex carbohydrates consumed cannot be absorbed into the small intestine in their original form. First, they must be hydrolyzed to a monosaccharide form such as glucose or galactose. These monosaccharides are then transported across the intestinal membrane and into the blood via transcellular transport. The intestinal epithelial cells allow the movement of these monosaccharides with a defined 'entry' through membrane transporter proteins present on their apical membrane and 'exit' via the...
01:20Inborn Errors of Metabolism
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
01:15Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...